Doyle John Brendan
SEC CIK 1840738 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGTX | COGNITION THERAPEUTICS INC | CFO | 618.9K | $11.3K | — | 15 | 2023-05-01 | 2026-05-01 |
Most active insiders at CGTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Doyle John Brendan | CFO | $11.3K | — |
| 2 | Caggiano Anthony | Chief Medical Off | $11.1K | — |
| 3 | Ricciardi Lisa | CEO, Pres, Dir | $10.1K | — |
| 4 | Wallace Peggy | Dir | — | — |
| 5 | Fletcher Aaron G.L. | Dir, 10% | — | — |
| 6 | Khattar Jack A. | Dir | — | — |
| 7 | Monia Brett P | Dir | — | — |
| 8 | RICHSTONE ELLEN B | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 16:01 | 2026-05-01 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | F - Tax | $1.28 | -8,567 | 618.9K | -1% | -$11.0K | |
| 2026-04-20 16:18 | 2026-04-16 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | P - Purchase | $1.13 | +10.0K | 627.5K | +2% | +$11.3K | |
| 2026-02-18 | 2026-02-15 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | F - Tax | $1.12 | -1,560 | 617.5K | -0.3% | -$1,747 | |
| 2026-02-05 | 2026-02-04 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | F - Tax | $1.03 | -26.9K | 619.1K | -4% | -$27.7K | |
| 2026-02-05 | 2026-02-03 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | A - Grant | $0.00 | +200.0K | 646.0K | +45% | $0 | |
| 2025-12-22 | 2025-12-18 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | F - Tax | $1.50 | -9,360 | 446.0K | -2% | -$14.0K | |
| 2025-12-22 | 2025-12-18 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | A - Grant | $0.00 | +30.0K | 455.4K | +7% | $0 | |
| 2025-07-31 | 2025-07-29 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | A - Grant | $0.00 | +30.0K | 434.7K | +7% | $0 | |
| 2025-07-31 | 2025-07-29 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | F - Tax | $0.67 | -9,360 | 425.4K | -2% | -$6,271 | |
| 2025-05-02 | 2025-05-01 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | F - Tax | $0.45 | -9,692 | 404.7K | -2% | -$4,361 | |
| 2025-02-18 | 2025-02-15 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | F - Tax | $0.59 | -1,723 | 414.4K | -0.4% | -$1,017 | |
| 2025-02-04 | 2025-02-04 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | A - Grant | $0.00 | +295.0K | 416.1K | +244% | $0 | |
| 2024-05-03 | 2024-05-01 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | F - Tax | $1.95 | -8,699 | 121.1K | -7% | -$17.0K | |
| D | 2024-02-20 | 2024-02-15 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | A - Grant | $0.00 | +20.0K | 129.8K | +18% | $0 |
| D | 2023-05-03 | 2023-05-01 | CGTX | COGNITION THERAPEUTICS INC | Doyle John Brendan | CFO | A - Grant | $0.00 | +109.8K | 109.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations